One Hall of Fame voter is done playing steroids police

46 Comments

This will be Pete Abraham of the Boston Globe’s third year as a Hall of Fame voter. In year one he decided no suspected steroid users will ever get his vote. In year two he softened his stance, only withholding votes from players who were documented steroid users.  This year, however, he has decided that it’s time to end all of that: PED use will not be a part of his analysis going forward. It will be all about what happened on the field.

Go read his column about his new approach. Note that, in changing his view of the matter, he is in no way endorsing PED use or absolving players of their cheating ways. He’s merely acknowledging that PEDs were a reality of the sport for a long time, that there are limits to what a voter can know, that consistency is important and that, ultimately, it is not the place of a baseball writer to become a judge of character as much as he or she is a judge of baseball prowess.

This is encouraging.

Chris Paddack loses no-hit bid in eighth inning vs. Marlins

Eric Espada/Getty Images
2 Comments

Update (9:16 PM ET): Aaaaaand it’s over. Just like that. Starlin Castro led off the eighth inning with a solo home run to left field. That ends the shutout bid as well, obviously.

*

Padres starter Chris Paddack has kept the Marlins hitless through seven innings on Wednesday evening in Miami. The right-hander has allowed two base runners on a throwing error and a walk while striking out seven on 82 pitches.

The Padres’ offense provided Paddack with three runs of support, all coming in the fourth on Greg Garcia‘s RBI single and a two-run home run by Austin Hedges.

Paddack, 23, entered Wednesday’s start carrying a 2.84 ERA with an 87/18 K/BB ratio across 82 1/3 innings in his rookie campaign.

Among all 30 teams, the Padres are the only one without a no-hitter. They came into the league in 1969. The Marlins were last victims of a no-hitter on September 28, 2014 when Jordan Zimmermann — then with the Nationals — accomplished the feat.